Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

Stopped early · Phase 3

Conditions studied: Obsessive Compulsive Disorder

In brief

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compulsive disorder (OCD).

Key facts

Study ID
NCT04708834
Run by
Biohaven Pharmaceuticals, Inc.
People needed
772
Starts
2021-03-30
Expected to finish
2026-02-13
Last updated by the study team
2026-02-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.